TreeWAS – Variant ID: rs474951

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N13 Obstructive and reflux uropathy	0.000	0.753	0.247
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.757	0.243
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.000	0.758	0.242
N13.8 Other obstructive and reflux uropathy	0.000	0.768	0.232
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.000	0.784	0.216
N13.7 Vesicoureteral-reflux-associated uropathy	0.000	0.799	0.201
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.808	0.192
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.810	0.190
N13.4 Hydroureter	0.000	0.817	0.183
N13.6 Pyonephrosis	0.000	0.846	0.154
N13.3 Other and unspecified hydronephrosis	0.000	0.886	0.114
N10-N16 Renal tubulo-interstitial diseases	0.000	0.924	0.076
N10 Acute tubulo-interstitial nephritis	0.000	0.935	0.065
N15 Other renal tubulo-interstitial diseases	0.000	0.935	0.064
N15.9 Renal tubulo-interstitial disease, unspecified	0.000	0.942	0.058
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.000	0.946	0.054
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.000	0.952	0.048
N11 Chronic tubulo-interstitial nephritis	0.000	0.953	0.047
N15.8 Other specified renal tubulo-interstitial diseases	0.000	0.953	0.046
N15.0 Balkan nephropathy	0.000	0.953	0.046
N15.1 Renal and perinephric abscess	0.000	0.957	0.043
N14.4 Toxic nephropathy, not elsewhere classified	0.000	0.961	0.039
N14.3 Nephropathy induced by heavy metals	0.000	0.961	0.039
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.000	0.961	0.039
N14.0 Analgesic nephropathy	0.000	0.961	0.039
T43.2 Other and unspecified antidepressants	0.039	0.961	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.000	0.962	0.038
H02.4 Ptosis of eyelid	0.037	0.963	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.000	0.964	0.036
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.000	0.965	0.035
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.000	0.965	0.035
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.000	0.965	0.035
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.000	0.965	0.035
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.000	0.965	0.035
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.000	0.965	0.035
N11.8 Other chronic tubulo-interstitial nephritis	0.000	0.966	0.034
N11.1 Chronic obstructive pyelonephritis	0.000	0.966	0.034
C25.0 Head of pancreas	0.033	0.967	0.000
C25 Malignant neoplasm of pancreas	0.031	0.969	0.000
C25.9 Pancreas, unspecified	0.031	0.969	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.000	0.971	0.028
C25.2 Tail of pancreas	0.026	0.974	0.000
C25.3 Pancreatic duct	0.025	0.975	0.000
C25.4 Endocrine pancreas	0.024	0.976	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.000	0.977	0.023
C25.8 Overlapping lesion of pancreas	0.022	0.978	0.000
C25.1 Body of pancreas	0.021	0.979	0.000
C25.7 Other parts of pancreas	0.021	0.979	0.000
R45.8 Other symptoms and signs involving emotional state	0.000	0.984	0.016
R45 Symptoms and signs involving emotional state	0.000	0.985	0.015
R45.1 Restlessness and agitation	0.000	0.986	0.014
R45.4 Irritability and anger	0.000	0.987	0.013
R45.5 Hostility	0.000	0.988	0.012
R45.2 Unhappiness	0.000	0.988	0.012
R45.6 Physical violence	0.000	0.988	0.012
R45.0 Nervousness	0.000	0.989	0.011
R45.7 State of emotional shock and stress, unspecified	0.000	0.989	0.011
R45.3 Demoralisation and apathy	0.000	0.989	0.011
E80.4 Gilbert's syndrome	0.011	0.989	0.000
J18.0 Bronchopneumonia, unspecified	0.008	0.992	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.007	0.993	0.000
S09.9 Unspecified injury of head	0.007	0.993	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.006	0.994	0.000
E28.2 Polycystic ovarian syndrome	0.006	0.994	0.000
Y45.8 Other analgesics and antipyretics	0.006	0.994	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.006	0.994	0.000
R09.0 Asphyxia	0.000	0.994	0.006
E80.6 Other disorders of bilirubin metabolism	0.006	0.994	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.006	0.994	0.000
E80.2 Other porphyria	0.006	0.994	0.000
C44.6 Skin of upper limb, including shoulder	0.000	0.994	0.006
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
E80.1 Porphyria cutanea tarda	0.005	0.994	0.000
E80.5 Crigler-Najjar syndrome	0.005	0.995	0.000
E80.3 Defects of catalase and peroxydase	0.005	0.995	0.000
E80.0 Hereditary erythropoietic porphyria	0.005	0.995	0.000
Y40.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
M76.67 Achilles tendinitis (Ankle and foot)	0.005	0.995	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.005	0.995	0.000
K08.3 Retained dental root	0.000	0.995	0.005
R47.0 Dysphasia and aphasia	0.005	0.995	0.000
M76.66 Achilles tendinitis (Lower leg)	0.005	0.995	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.995	0.005
M76.6 Achilles tendinitis	0.005	0.995	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.995	0.005
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y45.4 Antirheumatics	0.004	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.996	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.004	0.996	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.004	0.996	0.000
Y45.2 Propionic acid derivatives	0.004	0.996	0.000
Y40 Systemic antibiotics	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.996	0.004
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.996	0.004
Y45.1 Salicylates	0.004	0.996	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.996	0.004
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.004	0.996	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
Z32.1 Pregnancy confirmed	0.000	0.996	0.004
M76.69 Achilles tendinitis-Site unspec	0.003	0.996	0.000
M76.68 Achilles tendinitis-Other	0.003	0.996	0.000
M76.65 Achilles tendinitis-Pelvic/Thigh	0.003	0.996	0.000
M76.64 Achilles tendinitis-Hand	0.003	0.996	0.000
M76.63 Achilles tendinitis-Forearm	0.003	0.996	0.000
M76.62 Achilles tendinitis-Upper arm	0.003	0.996	0.000
M76.61 Achilles tendinitis-Shldr region	0.003	0.996	0.000
M76.60 Achilles tendinitis (Multiple sites)	0.003	0.996	0.000
Y53.2 Stimulant laxatives	0.004	0.996	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.004	0.996	0.000
O82.1 Delivery by emergency Caesarean section	0.000	0.996	0.004
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.996	0.000
Y51.0 Anticholinesterase agents	0.003	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.996	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.997	0.003
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
A04.8 Other specified bacterial intestinal infections	0.003	0.997	0.000
K38.8 Other specified diseases of appendix	0.000	0.997	0.003
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
M76 Enthesopathies of lower limb, excluding foot	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate	0.003	0.997	0.000
M96.5 Postradiation scoliosis	0.003	0.997	0.000
M96.4 Postsurgical lordosis	0.003	0.997	0.000
M96.3 Postlaminectomy kyphosis	0.003	0.997	0.000
M96.2 Postradiation kyphosis	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.003	0.997	0.000
H16.9 Keratitis, unspecified	0.000	0.997	0.003
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
S09 Other and unspecified injuries of head	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
N75.1 Abscess of Bartholin's gland	0.003	0.997	0.000
A46 Erysipelas	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
J47 Bronchiectasis	0.003	0.997	0.000
S92.0 Fracture of calcaneus	0.000	0.997	0.003
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
H54.7 Unspecified visual loss	0.000	0.997	0.003
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
M51.8 Other specified intervertebral disk disorders	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
G24.9 Dystonia, unspecified	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
O41.8 Other specified disorders of amniotic fluid and membranes	0.003	0.997	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.003	0.997	0.000
M76.0 Gluteal tendinitis	0.003	0.997	0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.997	0.003
M23.25 Derangement of meniscus due to old tear or injury (Posterior horn of lateral meniscus)	0.000	0.997	0.003
M76.8 Other enthesopathies of lower limb, excluding foot	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
S09.2 Traumatic rupture of ear drum	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.002	0.997	0.000
Y56.8 Other topical agents	0.002	0.997	0.000
Y56.7 Dental drugs, topically applied	0.002	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.997	0.000
Y56.2 Local astringents and local detergents	0.002	0.997	0.000
Y56.1 Antipruritics	0.002	0.997	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.997	0.003
N99.2 Postprocedural adhesions of vagina	0.000	0.997	0.003
M76.9 Enthesopathy of lower limb, unspecified	0.002	0.997	0.000
M76.7 Peroneal tendinitis	0.002	0.997	0.000
M76.5 Patellar tendinitis	0.002	0.997	0.000
M76.4 Tibial collateral bursitis [Pellegrini-Stieda]	0.002	0.997	0.000
M76.3 Iliotibial band syndrome	0.002	0.997	0.000
M76.2 Iliac crest spur	0.002	0.997	0.000
M76.1 Psoas tendinitis	0.002	0.997	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.997	0.003
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)	0.002	0.997	0.000
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate	0.002	0.997	0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.003	0.997	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.997	0.003
S09.0 Injury of blood vessels of head, not elsewhere classified	0.003	0.997	0.000
M76.05 Gluteal tendinitis (Pelvic region and thigh)	0.002	0.997	0.000
N99.5 Malfunction of external stoma of urinary tract	0.000	0.997	0.003
M76.86 Other enthesopathies of lower limb, excluding foot (Lower leg)	0.002	0.997	0.000
S09.7 Multiple injuries of head	0.002	0.997	0.000
S09.1 Injury of muscle and tendon of head	0.002	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
M95.0 Acquired deformity of nose	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
O82.9 Delivery by Caesarean section, unspecified	0.000	0.997	0.002
S92.01 Fracture of calcaneus (open)	0.000	0.997	0.002
G24.8 Other dystonia	0.002	0.997	0.000
H11.1 Conjunctival degenerations and deposits	0.002	0.997	0.000
Z46.8 Fitting and adjustment of other specified devices	0.000	0.997	0.002
M79.88 Other specified soft tissue disorders (Other)	0.002	0.998	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.002	0.998	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.002	0.998	0.000
M77.57 Other enthesopathy of foot-Ankle/Foot	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
S09.8 Other specified injuries of head	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
M79.8 Other specified soft tissue disorders	0.002	0.998	0.000
E28 Ovarian dysfunction	0.002	0.998	0.000
M76.09 Gluteal tendinitis-Site unspec	0.002	0.998	0.000
M76.08 Gluteal tendinitis-Other	0.002	0.998	0.000
M76.07 Gluteal tendinitis-Ankle/Foot	0.002	0.998	0.000
M76.06 Gluteal tendinitis-Lower Leg	0.002	0.998	0.000
M76.04 Gluteal tendinitis-Hand	0.002	0.998	0.000
M76.03 Gluteal tendinitis-Forearm	0.002	0.998	0.000
M76.02 Gluteal tendinitis-Upper arm	0.002	0.998	0.000
M76.01 Gluteal tendinitis-Shldr region	0.002	0.998	0.000
M76.00 Gluteal tendinitis (Multiple sites)	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.998	0.002
G37 Other demyelinating diseases of central nervous system	0.000	0.998	0.002
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.998	0.002
G24 Dystonia	0.002	0.998	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.998	0.002
K10.8 Other specified diseases of jaws	0.000	0.998	0.002
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
O82 Single delivery by Caesarean section	0.000	0.998	0.002
M76.89 Other enthesopathies of lower limb, excluding foot-Site uns	0.002	0.998	0.000
M76.88 Other enthesopathies of lower limb, excluding foot-Other	0.002	0.998	0.000
M76.85 Other enthesopathies of lower limb, excluding foot (Pelvic region and thigh)	0.002	0.998	0.000
M76.84 Other enthesopathies of lower limb, excluding foot-Hand	0.002	0.998	0.000
M76.83 Other enthesopathies of lower limb, excluding foot-Forearm	0.002	0.998	0.000
M76.82 Other enthesopathies of lower limb, excluding foot-Upper ar	0.002	0.998	0.000
M76.81 Other enthesopathies of lower limb, excluding foot-Shldr re	0.002	0.998	0.000
M76.80 Other enthesopathies of lower limb, excluding foot (Multiple sites)	0.002	0.998	0.000
M79.70 Fibromyalgia (Multiple sites)	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.002	0.998	0.000
I84.1 Internal haemorrhoids with other complications	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
N99.1 Postprocedural urethral stricture	0.000	0.998	0.002
Q51.3 Bicornate uterus	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
M79.79 Fibromyalgia (Site unspecified)	0.002	0.998	0.000
G24.3 Spasmodic torticollis	0.002	0.998	0.000
G37.8 Other specified demyelinating diseases of central nervous system	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
M76.19 Psoas tendinitis-Site unspec	0.002	0.998	0.000
M76.18 Psoas tendinitis-Other	0.002	0.998	0.000
M76.17 Psoas tendinitis-Ankle/Foot	0.002	0.998	0.000
M76.16 Psoas tendinitis-Lower Leg	0.002	0.998	0.000
M76.15 Psoas tendinitis (Pelvic region and thigh)	0.002	0.998	0.000
M76.14 Psoas tendinitis-Hand	0.002	0.998	0.000
M76.13 Psoas tendinitis-Forearm	0.002	0.998	0.000
M76.12 Psoas tendinitis-Upper arm	0.002	0.998	0.000
M76.11 Psoas tendinitis-Shldr region	0.002	0.998	0.000
M76.10 Psoas tendinitis (Multiple sites)	0.002	0.998	0.000
M76.29 Iliac crest spur-Site unspec	0.002	0.998	0.000
M76.28 Iliac crest spur-Other	0.002	0.998	0.000
M76.27 Iliac crest spur-Ankle/Foot	0.002	0.998	0.000
M76.26 Iliac crest spur-Lower Leg	0.002	0.998	0.000
M76.25 Iliac crest spur-Pelvic/Thigh	0.002	0.998	0.000
M76.24 Iliac crest spur-Hand	0.002	0.998	0.000
M76.23 Iliac crest spur-Forearm	0.002	0.998	0.000
M76.22 Iliac crest spur-Upper arm	0.002	0.998	0.000
M76.21 Iliac crest spur-Shldr region	0.002	0.998	0.000
M76.20 Iliac crest spur-Mult sites	0.002	0.998	0.000
M76.39 Iliotibial band syndrome-Site unspec	0.002	0.998	0.000
M76.38 Iliotibial band syndrome-Other	0.002	0.998	0.000
M76.37 Iliotibial band syndrome-Ankle/Foot	0.002	0.998	0.000
M76.36 Iliotibial band syndrome (Lower leg)	0.002	0.998	0.000
M76.35 Iliotibial band syndrome (Pelvic region and thigh)	0.002	0.998	0.000
M76.34 Iliotibial band syndrome-Hand	0.002	0.998	0.000
M76.33 Iliotibial band syndrome-Forearm	0.002	0.998	0.000
M76.32 Iliotibial band syndrome-Upper arm	0.002	0.998	0.000
M76.31 Iliotibial band syndrome-Shldr region	0.002	0.998	0.000
M76.30 Iliotibial band syndrome (Multiple sites)	0.002	0.998	0.000
M76.49 Tibial collateral bursitis [Pellegrini-Stieda]-Site unspec	0.002	0.998	0.000
M76.48 Tibial collateral bursitis [Pellegrini-Stieda]-Other	0.002	0.998	0.000
M76.47 Tibial collateral bursitis [Pellegrini-Stieda]-Ankle/Foot	0.002	0.998	0.000
M76.46 Tibial collateral bursitis [Pellegrini-Stieda]-Lower Leg	0.002	0.998	0.000
M76.45 Tibial collateral bursitis [Pellegrini-Stieda]-Pelvic/Thigh	0.002	0.998	0.000
M76.44 Tibial collateral bursitis [Pellegrini-Stieda]-Hand	0.002	0.998	0.000
M76.43 Tibial collateral bursitis [Pellegrini-Stieda]-Forearm	0.002	0.998	0.000
M76.42 Tibial collateral bursitis [Pellegrini-Stieda]-Upper arm	0.002	0.998	0.000
M76.41 Tibial collateral bursitis [Pellegrini-Stieda]-Shldr region	0.002	0.998	0.000
M76.40 Tibial collateral bursitis [Pellegrini-Stieda]-Mult sites	0.002	0.998	0.000
M76.59 Patellar tendinitis-Site unspec	0.002	0.998	0.000
M76.58 Patellar tendinitis-Other	0.002	0.998	0.000
M76.57 Patellar tendinitis-Ankle/Foot	0.002	0.998	0.000
M76.56 Patellar tendinitis-Lower Leg	0.002	0.998	0.000
M76.55 Patellar tendinitis-Pelvic/Thigh	0.002	0.998	0.000
M76.54 Patellar tendinitis-Hand	0.002	0.998	0.000
M76.53 Patellar tendinitis-Forearm	0.002	0.998	0.000
M76.52 Patellar tendinitis-Upper arm	0.002	0.998	0.000
M76.51 Patellar tendinitis-Shldr region	0.002	0.998	0.000
M76.50 Patellar tendinitis-Mult sites	0.002	0.998	0.000
M76.79 Peroneal tendinitis-Site unspec	0.002	0.998	0.000
M76.78 Peroneal tendinitis-Other	0.002	0.998	0.000
M76.77 Peroneal tendinitis (Ankle and foot)	0.002	0.998	0.000
M76.76 Peroneal tendinitis (Lower leg)	0.002	0.998	0.000
M76.75 Peroneal tendinitis-Pelvic/Thigh	0.002	0.998	0.000
M76.74 Peroneal tendinitis-Hand	0.002	0.998	0.000
M76.73 Peroneal tendinitis-Forearm	0.002	0.998	0.000
M76.72 Peroneal tendinitis-Upper arm	0.002	0.998	0.000
M76.71 Peroneal tendinitis-Shldr region	0.002	0.998	0.000
M76.70 Peroneal tendinitis (Multiple sites)	0.002	0.998	0.000
M76.99 Enthesopathy of lower limb, unspecified (Site unspecified)	0.002	0.998	0.000
M76.98 Enthesopathy of lower limb, unspecified (Other)	0.002	0.998	0.000
M76.97 Enthesopathy of lower limb, unspecified (Ankle and foot)	0.002	0.998	0.000
M76.96 Enthesopathy of lower limb, unspecified (Lower leg)	0.002	0.998	0.000
M76.95 Enthesopathy of lower limb, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M76.94 Enthesopathy of lower limb, unspecified-Hand	0.002	0.998	0.000
M76.93 Enthesopathy of lower limb, unspecified-Forearm	0.002	0.998	0.000
M76.92 Enthesopathy of lower limb, unspecified-Upper arm	0.002	0.998	0.000
M76.91 Enthesopathy of lower limb, unspecified-Shldr region	0.002	0.998	0.000
M76.90 Enthesopathy of lower limb, unspecified (Multiple sites)	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.002	0.998	0.000
H16 Keratitis	0.000	0.998	0.002
M76.87 Other enthesopathies of lower limb, excluding foot (Ankle and foot)	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
M50.0 Cervical disk disorder with myelopathy	0.002	0.998	0.000
M95.2 Other acquired deformity of head	0.002	0.998	0.000
E53.8 Deficiency of other specified B group vitamins	0.002	0.998	0.000
G24.1 Idiopathic familial dystonia	0.002	0.998	0.000
M77.5 Other enthesopathy of foot	0.002	0.998	0.000
S92.3 Fracture of metatarsal bone	0.000	0.998	0.002
M99 Biomechanical lesions, not elsewhere classified	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.002	0.998	0.000
M79.82 Other specified soft tissue disorders (Upper arm)	0.002	0.998	0.000
E14.3 With ophthalmic complications	0.000	0.998	0.002
M79.7 Fibromyalgia	0.002	0.998	0.000
M95.3 Acquired deformity of neck	0.002	0.998	0.000
T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified	0.002	0.998	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.002	0.998	0.000
M95.8 Other specified acquired deformities of musculoskeletal system	0.002	0.998	0.000
M95.5 Acquired deformity of pelvis	0.002	0.998	0.000
M95.1 Cauliflower ear	0.002	0.998	0.000
R61 Hyperhidrosis	0.000	0.998	0.002
H11.3 Conjunctival haemorrhage	0.002	0.998	0.000
N99.0 Postprocedural renal failure	0.000	0.998	0.002
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.000	0.998	0.002
E21.0 Primary hyperparathyroidism	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
R09 Other symptoms and signs involving the circulatory and respiratory systems	0.000	0.998	0.002
M79.84 Other specified soft tissue disorders (Hand)	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
T98.1 Sequelae of other and unspecified effects of external causes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.002	0.998	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.000	0.998	0.002
H16.2 Keratoconjunctivitis	0.000	0.998	0.002
M06.0 Seronegative rheumatoid arthritis	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
E28.9 Ovarian dysfunction, unspecified	0.002	0.998	0.000
E28.8 Other ovarian dysfunction	0.002	0.998	0.000
E28.1 Androgen excess	0.002	0.998	0.000
E28.0 Oestrogen excess	0.002	0.998	0.000
G37.5 Concentric sclerosis [Balo]	0.000	0.998	0.002
G37.4 Subacute necrotising myelitis	0.000	0.998	0.002
G37.2 Central pontine myelinolysis	0.000	0.998	0.002
G37.1 Central demyelination of corpus callosum	0.000	0.998	0.002
G37.0 Diffuse sclerosis	0.000	0.998	0.002
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.000	0.998	0.002
G24.4 Idiopathic orofacial dystonia	0.002	0.998	0.000
G24.2 Idiopathic nonfamilial dystonia	0.002	0.998	0.000
G24.0 Drug-induced dystonia	0.002	0.998	0.000
O82.8 Other single delivery by Caesarean section	0.000	0.998	0.002
O82.2 Delivery by Caesarean hysterectomy	0.000	0.998	0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
C69.0 Conjunctiva	0.002	0.998	0.000
G51.8 Other disorders of facial nerve	0.002	0.998	0.000
Q53.1 Undescended testicle, unilateral	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
H16.8 Other keratitis	0.000	0.998	0.002
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.000	0.998	0.002
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
J38.7 Other diseases of larynx	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.001	0.998	0.000
Y48.1 Parenteral anaesthetics	0.001	0.998	0.000
Y48.0 Inhaled anaesthetics	0.001	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
M77 Other enthesopathies	0.002	0.998	0.000
H11.9 Disorder of conjunctiva, unspecified	0.002	0.998	0.000
M50.3 Other cervical disk degeneration	0.002	0.998	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.002	0.998	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.002	0.998	0.000
B44.1 Other pulmonary aspergillosis	0.002	0.998	0.000
M50.1 Cervical disk disorder with radiculopathy	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
H16.4 Corneal neovascularisation	0.000	0.998	0.002
H16.3 Interstitial and deep keratitis	0.000	0.998	0.002
M77.1 Lateral epicondylitis	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations